tiprankstipranks
CSAM Health Group AS (DE:6Q1)
FRANKFURT:6Q1
Germany Market
Holding DE:6Q1?
Track your performance easily

CSAM Health Group AS (6Q1) Financial Statements

0 Followers

CSAM Health Group AS Financial Overview

CSAM Health Group AS's market cap is currently ―. The company's EPS TTM is €-0.088; its P/E ratio is -27.18; and it has a dividend yield of 1.70%. CSAM Health Group AS is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is €<0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenuekr 97.22Mkr 86.04Mkr 89.36Mkr 94.04Mkr 87.43M
Gross Profitkr 87.48Mkr 78.69Mkr 80.53Mkr 86.59Mkr 78.43M
EBITkr -50.05Mkr -17.27Mkr -11.25Mkr -20.56Mkr -32.56M
EBITDAkr -22.41Mkr 4.88Mkr 9.48Mkr 1.67Mkr -10.98M
Net Income Common Stockholderskr -58.72Mkr -25.22Mkr -19.72Mkr -27.94Mkr -42.47M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investmentskr 191.81Mkr 231.70Mkr 261.00Mkr 280.05Mkr 277.44M
Total Assetskr 693.54Mkr 705.49Mkr 751.86Mkr 772.93Mkr 815.13M
Total Debtkr 494.43Mkr 493.71Mkr 492.93Mkr 491.36Mkr 491.36M
Net Debtkr 302.62Mkr 262.01Mkr 231.93Mkr 211.31Mkr 213.91M
Total Liabilitieskr 664.77Mkr 611.53Mkr 643.94Mkr 648.80Mkr 648.53M
Stockholders Equitykr 28.77Mkr 93.95Mkr 107.92Mkr 124.13Mkr 166.60M
Cash Flow-
Free Cash Flowkr -28.14Mkr -20.88Mkr -10.66Mkr 29.46Mkr -10.39M
Operating Cash Flowkr -15.26Mkr -11.43Mkr -1.34Mkr 39.46Mkr -2.38M
Investing Cash Flowkr -10.00Mkr -9.45Mkr -9.32Mkr -33.01Mkr 6.06M
Financing Cash Flowkr -10.54Mkr -8.41Mkr -8.39Mkr -7.26Mkr -10.74M
Currency in NOK

CSAM Health Group AS Earnings and Revenue History

CSAM Health Group AS Debt to Assets

CSAM Health Group AS Cash Flow

CSAM Health Group AS Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis